Nogapendekin Alfa Benefits Survival in NMIBC
Nogapendekin Alfa Combo Shows Survival Benefits in BCG-Unresponsive NMIBC
| Read More |
FDA Grants Fast Track Designation to GPC3x4-1BB Bispecific Antibody in HCC
| Read More |
Videos
|
All-Oral Elacestrant Combos Offer “Tremendous” Benefits in Breast Cancer
|
A Pathologist’s Crucial Role in Diagnosing Breast Cancer
|
Trending
|
ASH 2025: Key Discussions in Multiple Myeloma, Lymphoma, and Leukemia
|
Omitting Sentinel Lymph Node Biopsy Is Safe in Select Patients With HR+ Early Breast Cancer
|